The novel therapy of this peptide represents a major advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects two pathways – GLP-1 and the GIP hormone – leading to https://tirzepatidepeptide311080.csublogs.com/49958169/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment